These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 16212920)
1. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Pan H; Hong F; Radaeva S; Gao B Cell Mol Immunol; 2004 Feb; 1(1):43-9. PubMed ID: 16212920 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Radaeva S; Sun R; Pan HN; Hong F; Gao B Hepatology; 2004 May; 39(5):1332-42. PubMed ID: 15122762 [TBL] [Abstract][Full Text] [Related]
6. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498 [TBL] [Abstract][Full Text] [Related]
7. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. Kovalovich K; Li W; DeAngelis R; Greenbaum LE; Ciliberto G; Taub R J Biol Chem; 2001 Jul; 276(28):26605-13. PubMed ID: 11349125 [TBL] [Abstract][Full Text] [Related]
9. Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy. Zhou H; Xie G; Mao Y; Zhou K; Ren R; Zhao Q; Wang H; Yin S J Immunol Res; 2018; 2018():5241526. PubMed ID: 30515423 [TBL] [Abstract][Full Text] [Related]
10. IL-38 alleviates concanavalin A-induced liver injury in mice. Yuan X; Li Y; Pan X; Peng X; Song G; Jiang W; Gao Q; Li M Int Immunopharmacol; 2016 Nov; 40():452-457. PubMed ID: 27723569 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Li B; Sun R; Wei H; Gao B; Tian Z Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307 [TBL] [Abstract][Full Text] [Related]
12. Over-expression of Roquin aggravates T cell mediated hepatitis in transgenic mice using T cell specific promoter. Ji YR; Kim HJ; Yu DH; Bae KB; Park SJ; Park SJ; Jang WY; Kang MC; Jeong J; Sung YH; Choi M; Park T; Park T; Yun JW; Lee HS; Lee S; Kim MO; Ryoo ZY Biochem Biophys Res Commun; 2014 Sep; 452(3):822-7. PubMed ID: 25201726 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-22 contributes to liver regeneration in mice with concanavalin A-induced hepatitis after hepatectomy. Zhang YM; Liu ZR; Cui ZL; Yang C; Yang L; Li Y; Shen ZY World J Gastroenterol; 2016 Feb; 22(6):2081-91. PubMed ID: 26877612 [TBL] [Abstract][Full Text] [Related]
14. TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis. Arshad MI; Piquet-Pellorce C; L'Helgoualc'h A; Rauch M; Patrat-Delon S; Ezan F; Lucas-Clerc C; Nabti S; Lehuen A; Cubero FJ; Girard JP; Trautwein C; Samson M Hepatology; 2012 Dec; 56(6):2353-62. PubMed ID: 22961755 [TBL] [Abstract][Full Text] [Related]
15. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448 [TBL] [Abstract][Full Text] [Related]
16. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. Ksontini R; Colagiovanni DB; Josephs MD; Edwards CK; Tannahill CL; Solorzano CC; Norman J; Denham W; Clare-Salzler M; MacKay SL; Moldawer LL J Immunol; 1998 Apr; 160(8):4082-9. PubMed ID: 9558119 [TBL] [Abstract][Full Text] [Related]
17. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Lafdil F; Wang H; Park O; Zhang W; Moritoki Y; Yin S; Fu XY; Gershwin ME; Lian ZX; Gao B Gastroenterology; 2009 Dec; 137(6):2125-35.e1-2. PubMed ID: 19686746 [TBL] [Abstract][Full Text] [Related]
18. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Yamada Y; Fausto N Am J Pathol; 1998 Jun; 152(6):1577-89. PubMed ID: 9626061 [TBL] [Abstract][Full Text] [Related]
19. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Santucci L; Fiorucci S; Cammilleri F; Servillo G; Federici B; Morelli A Hepatology; 2000 Feb; 31(2):399-406. PubMed ID: 10655263 [TBL] [Abstract][Full Text] [Related]
20. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease. Lee KC; Lin HC; Huang YH; Hung SC J Hepatol; 2015 Dec; 63(6):1405-12. PubMed ID: 26276675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]